WWE & AEW Cannabis Policy 2026: Wellness Programs Explained

WWE Talent Wellness Program (post-Eddie Guerrero 2006, post-Chris Benoit 2007) softened cannabis penalties in 2019-2020. AEW under Tony Khan since 2019 takes a more lenient posture. Rob Van Dam, Ric Flair Drip, Snoop Dogg, and the wrestler-founded cannabis brand wave.

Status: Tested But Softened Tested, fines only

Pro wrestling sits in an unusual policy position. WWE and AEW are not WADA Code signatories, not athletic-commission-regulated, and not collectively bargained — their cannabis policies are private, contractual Wellness Programs closer in structure to MLB's Joint Drug Program than to WADA's S8 cannabinoids list. This page tracks what is publicly knowable about both promotions, the wrestlers whose cases shaped current policy, and the wrestler-founded cannabis-brand wave.

The WWE Talent Wellness Program (2006)

The WWE Talent Wellness Program was instituted on February 27, 2006, in the aftermath of the death of Eddie Guerrero (born October 9, 1967; died November 13, 2005, age 38, of acute heart failure linked to past anabolic-steroid and substance use). The program tested talent under contract for anabolic steroids, recreational drugs (including cannabis), and prescription-drug abuse, with on-staff medical-director oversight and an escalating fine-and-suspension schedule.

The program was substantially expanded in the wake of the Chris Benoit double-murder-suicide on June 22-25, 2007, which produced congressional attention to professional wrestling drug culture and pushed WWE to publish its policy framework more transparently. The 2007-2009 period was the most punitive era of the Wellness Program, with multiple high-profile suspensions for steroid and prescription-drug positives.

The Cannabis-Specific Shift (2019-2020)

WWE's cannabis-specific posture softened publicly around 2019-2020, in parallel with the broader North American pro-sports reform wave (the December 12, 2019 MLB removal, the March 2020 NFL CBA, the eventual July 1, 2023 NBA CBA). The direction of the shift was clear — cannabis-positive findings moved away from suspensions and toward reduced-fine treatment — though WWE has not published every threshold and dollar figure in detail, and the policy continues to evolve between contract cycles. Treat any specific number you read about WWE cannabis penalties as likely-current rather than verified, and consult representation before relying. Limited evidence

What is consistent across pre- and post-reform WWE policy: cannabis is not on the Performance-Enhancing Substances list. The PES enforcement (anabolic steroids, growth hormone, masking agents) has remained the program's serious end of the schedule. Cannabis lives on the "drugs of abuse" side, alongside the program's prescription-drug-abuse focus that originally motivated its creation.

Rob Van Dam (July 2006): The Defining Wellness-Policy Cannabis Case

The first highly visible cannabis disposition under the new Wellness Program was Rob Van Dam (Robert Szatkowski). On July 22, 2006, RVD and Sabu were stopped by police on Long Island and found in possession of cannabis and five Vicodin pills. RVD was at the time both the WWE Champion and the ECW Champion under the WWE-relaunched ECW brand — a dual-title position no other wrestler held during the WWE-ECW relaunch period. He was suspended 30 days, lost both titles on TV, and the storyline was rewritten to drop the championships back to other talent.

RVD has spoken openly about the case in podcasts and interviews in the years since and has become one of professional wrestling's most public cannabis advocates. He launched RVD CBD as a personal CBD brand drawing on the post-2018 Farm Bill hemp framework.

Wrestler-Founded Cannabis Brands

Pro wrestling has joined the NBA-alumni and NFL-alumni pathway into athlete-founded cannabis ventures, anchored by three names:

  • Ric Flair Drip — a partnership Flair launched in 2021 with Carma HoldCo — the same parent company behind Mike Tyson's TYSON 2.0 (see Mike Tyson & TYSON 2.0 and Athlete-Founded Cannabis Brands).
  • RVD CBD — Rob Van Dam's CBD line in the post-2018 Farm Bill hemp market.
  • Snoop Dogg — inducted into the WWE Hall of Fame celebrity wing in 2024 and a longstanding cultural connector between wrestling and cannabis. Snoop's wider cannabis-brand portfolio is documented across the cannabis-business press.

The Carma HoldCo footprint is notable on its own: a single corporate structure now sits behind two of the most recognizable athlete-cannabis brands in the U.S. (TYSON 2.0 and Ric Flair Drip), connecting the WWE Hall of Fame and former-heavyweight-champion ecosystems through one operator. The November 12, 2026 federal hemp cliff under PL 119-37 § 781 will reshape the operating environment for any wrestler-CBD brand built on the 2018 Farm Bill hemp framework.

AEW: A More Lenient Posture Since 2019

All Elite Wrestling (AEW) was founded on January 1, 2019 by Tony Khan (son of Jacksonville Jaguars owner Shahid Khan) and ran its first pay-per-view Double or Nothing on May 25, 2019. AEW operates a Wellness Policy structurally similar to WWE's — PES enforcement on one side, drugs-of-abuse on the other — but is widely understood within the industry to take a substantially more lenient posture on cannabis specifically. Multiple AEW-rostered wrestlers have spoken openly about cannabis use without disciplinary consequence. Limited evidence

AEW has not published every threshold and dollar figure in its Wellness Policy, so the same caveat applies: treat AEW cannabis posture as publicly lenient rather than publicly defined, and consult your representation before relying on it for high-stakes decisions.

Why Pro Wrestling Sits Outside the Anti-Doping Framework

Three structural facts distinguish pro wrestling from every other category of athlete on this site:

  • No WADA / USADA / NCAA / state-commission jurisdiction — WWE and AEW are entertainment-classified, not regulated combat sport. They are not Code signatories, not commission-licensed, and not testing under the WADA Prohibited List or the NSAC framework. Wrestler cannabis policy is contractual, not anti-doping.
  • No collective-bargaining counterparty — pro wrestlers are independent contractors under both WWE and AEW. There is no wrestlers' union, no NFLPA / NBPA / MLBPA equivalent, and therefore no collectively-bargained Wellness Program in the way the U.S. major leagues bargain their policies. Talent has no collective seat at the table when policy changes.
  • Cross-over risk for crossover athletes — a wrestler who takes a sanctioned MMA or boxing bout is suddenly under the relevant athletic-commission rules for that bout, where the post-July 2021 NSAC and post-January 2024 CSAD posture (see UFC & Combat Sports and State Athletic Commissions) governs cannabis. Wrestlers should not assume their promotion's posture travels with them.

Practical Guidance for Wrestlers and Talent Reps

Five things every wrestler and talent representative should do before relying on any cannabis-related decision:

  1. Verify the current contract. WWE and AEW Wellness Policies change between contract cycles. The version you signed in 2022 may not be the version enforced in 2026. Pull the current document.
  2. Distinguish CBD from THC. CBD itself is not the issue — THC contamination of CBD products is. The Bonn-Miller JAMA 2017 finding — 21% of online CBD products contained THC and 69% were mislabeled overall — applies to wrestlers exactly as it applies to NFL and Olympic athletes. Use NSF Certified for Sport CBD if testing is in play.
  3. Plan for crossover bouts. If you are taking a commission-regulated MMA or boxing bout, the WWE/AEW posture does not protect you — commission rules govern. See Washout Protocols for the 2-6 week ranges by use intensity.
  4. Plan for international tours. WWE and AEW tour internationally. Country-by-country travel risk for hemp-derived CBD is real (see Brittney Griner as the extreme case). Do not assume U.S. hemp legality crosses borders.
  5. Plan for the November 12, 2026 hemp cliff. If a wrestler-CBD brand or a wrestler's personal CBD use depends on 2018-Farm-Bill hemp products, PL 119-37 § 781 reshapes the legal market in a way that may eliminate ~95% of currently-sold hemp-derived cannabinoid products.